Don't Just Read the News, Understand It.
Get Started
SubscribeLogin
Israel-Hamas Conflict
Juneteenth
Artificial Intelligence
Heatwaves
European Union
Social Media
Stock Markets
War
Cryptocurrency
Infrastructure
Corruption
Military
Education
Published • loading... • Updated

Breakthrough: FDA Grants Historic First Approval for Bullous Pemphigoid Treatment to Regeneron's Dupixent

Summary by stocktitan.net
First-ever targeted therapy for 27,000 US adults with Bullous Pemphigoid shows promising remission rates in elderly patients. See clinical trial results.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
stocktitan.netstocktitan.net

Breakthrough: FDA Grants Historic First Approval for Bullous Pemphigoid Treatment to Regeneron's Dupixent

First-ever targeted therapy for 27,000 US adults with Bullous Pemphigoid shows promising remission rates in elderly patients. See clinical trial results.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

stocktitan.net broke the news in on Friday, June 20, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

United States icon

United States

News
For You
SearchBlindspotLocal